Price alert —
Sign in to get a one-time email the moment GILD crosses your price. Free accounts included.
Sign in / create a free accountGilead Sciences, Inc. is a healthcare company listed in the US.
GILD last traded at $134.28, down 1.5% on the day; that's in the middle part of its 52-week range ($121.39–$157.29). Right now it's trading close to its recent average, with no strong stretch in either direction.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 57), the trend is quiet (ADX 18), and volume is about normal (0.8×). On the business side, revenue is growing 4% year over year and the business keeps about 27 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $98.35 (fair range $71–$132); today's price sits 37% above that estimate. The model's verdict is “Overvalued” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Positive retained earnings
- ✓ Gross margin 79% (pricing power)
- ✓ Net margin 31%
- ⚠ Debt exceeds cash
- ⚠ Receivables growing faster than revenue
Price implies ~9% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
GILD is a $161.8 billion company, priced at 18× last year's earnings.